用户名: 密码: 验证码:
The impact of clinical parameters on progression-free survival of non-small cell lung cancer patients harboring EGFR-mutations receiving first-line EGFR-tyrosine kinase inhibitors
详细信息    查看全文
文摘

Prognostic factors for EGFRm NSCLC receiving first-line EGFR-TKIs are explored.

Age, mutation, performance status and number of metastases are found to affect PFS.

Blood lymphocyte to monocyte ratio also independently affect PFS.

PFS score is created on a test dataset, and is validated on a validation dataset.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700